BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3784980)

  • 1. Neuro-ocular damage in pediatric oncology patients: predictor of long-term visual disability or tool for limiting toxicity?
    Newman NM; Donaldson S; de Wit S; King O; Wilbur JR
    Med Pediatr Oncol; 1986; 14(5):262-70. PubMed ID: 3784980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study.
    Saeed P; Blank L; Selva D; Wolbers JG; Nowak PJ; Geskus RB; Weis E; Mourits MP; Rootman J
    Br J Ophthalmol; 2010 May; 94(5):564-8. PubMed ID: 20447964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friendly fire: neurogenic visual loss from radiation therapy.
    Lessell S
    J Neuroophthalmol; 2004 Sep; 24(3):243-50. PubMed ID: 15348995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual results and ocular complications following radiotherapy for retinoblastoma.
    Egbert PR; Donaldson SS; Moazed K; Rosenthal AR
    Arch Ophthalmol; 1978 Oct; 96(10):1826-30. PubMed ID: 697618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual dysfunction in retinal and optic nerve disease.
    Murtha T; Stasheff SF
    Neurol Clin; 2003 May; 21(2):445-81. PubMed ID: 12916487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study on optic neuropathy and retinopathy subsequent to radiotherapy of nasopharyngeal carcinoma].
    Zhou P; Wang SF; Miao CH
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):616-20. PubMed ID: 14766077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced injury to the visual pathway.
    Jiang GL; Tucker SL; Guttenberger R; Peters LJ; Morrison WH; Garden AS; Ha CS; Ang KK
    Radiother Oncol; 1994 Jan; 30(1):17-25. PubMed ID: 8153376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic optic neuropathy and retinopathy associated with colon adenocarcinoma.
    Chao D; Chen WC; Thirkill CE; Lee AG
    Can J Ophthalmol; 2013 Oct; 48(5):e116-20. PubMed ID: 24093201
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy.
    Borruat FX; Schatz NJ; Glaser JS; Feun LG; Matos L
    J Clin Neuroophthalmol; 1993 Jun; 13(2):98-101. PubMed ID: 8340486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of electrophysiology in determining the diagnosis of visual dysfunction in neuro-ophthalmology patients.
    Yap GH; Chen LY; Png R; Loo JL; Tow S; Mathur R; Chia A
    Doc Ophthalmol; 2015 Dec; 131(3):189-96. PubMed ID: 26471028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual field loss following vitreous surgery.
    Kerrison JB; Haller JA; Elman M; Miller NR
    Arch Ophthalmol; 1996 May; 114(5):564-9. PubMed ID: 8619766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late retinal complications of radiation therapy for nasal and paranasal malignancies: relationship between irradiated-dose area and severity.
    Takeda A; Shigematsu N; Suzuki S; Fujii M; Kawata T; Kawaguchi O; Uno T; Takano H; Kubo A; Ito H
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):599-605. PubMed ID: 10348290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of the lateral geniculate body and visual function].
    Bunin AIa; Iakovlev AA
    Vestn Oftalmol; 2003; 119(1):46-9. PubMed ID: 12608048
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do visual evoked potentials give relevant information to the neuro-ophthalmological examination in optic nerve lesions?
    Nikoskelainen E; Falck B
    Acta Neurol Scand; 1982 Jul; 66(1):42-57. PubMed ID: 7113679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual system involvement in patients with Friedreich's ataxia.
    Fortuna F; Barboni P; Liguori R; Valentino ML; Savini G; Gellera C; Mariotti C; Rizzo G; Tonon C; Manners D; Lodi R; Sadun AA; Carelli V
    Brain; 2009 Jan; 132(Pt 1):116-23. PubMed ID: 18931386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delayed cost of treatment.
    Whipple KM; Levi L; Lee MS
    Surv Ophthalmol; 2013; 58(4):370-6. PubMed ID: 22784679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unanticipated vision loss after pars plana vitrectomy.
    Jain N; McCuen BW; Mruthyunjaya P
    Surv Ophthalmol; 2012; 57(2):91-104. PubMed ID: 22337337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.